Due to the known association between tumor genotype and programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) expression in the TME, we evaluated whether PD-1/PD-L1 expression varied across the 4 tumor models (48, 49). The gene discussed is CD274; the disease is neoplasm.